Epidemiological Trends and the Advances of Treatments of Amphetamine-Type Stimulants (ATS) in China
Hongqiang Sun,Hongmei Chen,Fude Yang,Lin Lü,Thomas R. Kosten
DOI: https://doi.org/10.1111/j.1521-0391.2013.12116.x
2013-01-01
Abstract:The American Journal on AddictionsVolume 23, Issue 3 p. 313-317 Review Article Epidemiological trends and the advances of treatments of amphetamine-type stimulants (ATS) in China Hong-Qiang Sun MD, PhD, Hong-Qiang Sun MD, PhD Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas Department of Alcohol and Drug Dependence, Beijing Hui-Long-Guan Hospital, Peking University, Beijing, ChinaSearch for more papers by this authorHong-Mei Chen MD, Hong-Mei Chen MD Department of Alcohol and Drug Dependence, Beijing Hui-Long-Guan Hospital, Peking University, Beijing, ChinaSearch for more papers by this authorFu-De Yang MD, Fu-De Yang MD Department of Alcohol and Drug Dependence, Beijing Hui-Long-Guan Hospital, Peking University, Beijing, ChinaSearch for more papers by this authorLin Lu MD, PhD, Lin Lu MD, PhD National Institute on Drug Dependence, Peking University, Beijing, ChinaSearch for more papers by this authorThomas R. Kosten MD, Corresponding Author Thomas R. Kosten MD Department of Psychiatry, Neuroscience, and Pharmacology, Baylor College of Medicine, Houston, Texas Michael E. DeBakey Veteran Affairs Medical Center, Houston, TexasAddress correspondence to Thomas R. Kosten, M.D., Department of Psychiatry, Neuroscience, and Pharmacology, Baylor College of Medicine, Houston, TX 77030; Department of Veteran Affairs Medical Center, 2002 Holcombe Blvd BLDG 121, Room 141, Houston, TX 77030. E-mail: kosten@bcm.eduSearch for more papers by this author Hong-Qiang Sun MD, PhD, Hong-Qiang Sun MD, PhD Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas Department of Alcohol and Drug Dependence, Beijing Hui-Long-Guan Hospital, Peking University, Beijing, ChinaSearch for more papers by this authorHong-Mei Chen MD, Hong-Mei Chen MD Department of Alcohol and Drug Dependence, Beijing Hui-Long-Guan Hospital, Peking University, Beijing, ChinaSearch for more papers by this authorFu-De Yang MD, Fu-De Yang MD Department of Alcohol and Drug Dependence, Beijing Hui-Long-Guan Hospital, Peking University, Beijing, ChinaSearch for more papers by this authorLin Lu MD, PhD, Lin Lu MD, PhD National Institute on Drug Dependence, Peking University, Beijing, ChinaSearch for more papers by this authorThomas R. Kosten MD, Corresponding Author Thomas R. Kosten MD Department of Psychiatry, Neuroscience, and Pharmacology, Baylor College of Medicine, Houston, Texas Michael E. DeBakey Veteran Affairs Medical Center, Houston, TexasAddress correspondence to Thomas R. Kosten, M.D., Department of Psychiatry, Neuroscience, and Pharmacology, Baylor College of Medicine, Houston, TX 77030; Department of Veteran Affairs Medical Center, 2002 Holcombe Blvd BLDG 121, Room 141, Houston, TX 77030. E-mail: kosten@bcm.eduSearch for more papers by this author First published: 11 April 2014 https://doi.org/10.1111/j.1521-0391.2014.12116.xCitations: 8Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract Background and Objectives Amphetamine-type stimulants (ATS) have quickly spread and been widely abused in many parts of the world, particularly in China. This review focuses on and describes the epidemiological trends and the advances of treatments of ATS in China. Methods A descriptive study based on literature identified from searches of the China National Knowledge Infrastructure (1979–2013), PubMed databases, hand-picked references, and online references with emphasis on epidemiology, treatment and traditional Chinese medicine. This review covers some traditional Chinese treatments and their complementary Western approaches. Results and Conclusions The epidemiological trends of ATS in China have led to its being 2.2 times the rate of morphine abuse and second only to marijuana abuse. The treatment programs in China have used traditional herbal approaches as well as acupuncture, often in combination with Western medications such as fluoxetine for depression associated with ATS abuse. Other herbal treatments have reversed the cardiac arrhythmias associated with ATS intoxication, and acupuncture has been used successfully for the protracted depressive and somatic symptoms of ATS withdrawal over a period of 3 months. Scientific Significance These traditional Chinese treatments may be increasingly available to the world, but will remain a consistent complementary therapy for ATS in China and the Far East, where ATS has become such a prevalent problem. (Am J Addict 2014;23:313–317) Citing Literature Volume23, Issue3May/June 2014Pages 313-317 RelatedInformation